This federal contract award, valued at $13,320.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Xarelto 20 mg tablets, a cardiovascular medication.
The award is a delivery order against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no specific set-aside designation, indicating open competition.
In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/16/25, 12:44 AM